GoodRx Q3 Revenue Outlook $193M-$197M Vs, $202.4M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoodRx has provided its Q3 2024 revenue outlook, projecting $193M-$197M, which is below the $202.4M estimate. The company expects a year-over-year revenue increase of 7%-9% and an adjusted EBITDA margin of approximately 32%.
August 08, 2024 | 10:08 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GoodRx's Q3 2024 revenue outlook of $193M-$197M is below the $202.4M estimate, which may lead to short-term negative sentiment. However, the company expects a year-over-year revenue increase of 7%-9% and an adjusted EBITDA margin of approximately 32%.
The revenue outlook being below the estimate is likely to cause short-term negative sentiment among investors. However, the expected year-over-year revenue growth and strong adjusted EBITDA margin may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100